Prevalence of Human Papillomavirus (HPV) Genotypes Among Women During 2015-2020 in Mashhad, Iran

Overview

Journal Arch Iran Med

Specialty General Medicine

Date 2024 Feb 1

PMID 38301103

Authors

Anis Bakhshani

Rashin Ganjali

Seyed-Elias Tabatabaeizadeh

Affiliations

Soon will be listed here.

Abstract

Background: Cervical cancer is the fourth most common cancer in women, and human papillomavirus (HPV) is the leading cause of cervical cancer. Cervical cancer screening and HPV vaccination are important in the incidence of cervical cancer.

Methods: This study was performed on Liquid Base Cytology (LBC) samples of 1214 women in Mashhad who were referred for cervical cancer screening in 2015-2020. Samples were examined by Single-Step PCR and Reverse Line Blot for HPV genotyping.

Results: 386 women (31.8%) were HPV PCR positive. HPV genotyping of 277 samples showed that HPV 31 (3%), 16 (2.5%), 51 (2.2%), 18 (2%), and 66 (1.8%) were the most prevalent high-risk HPV (hrHPV) genotypes. Among low-risk HPV (lrHPV) genotypes, HPV 6 (9.2%), 53 (4.7%), and 42 (2.8%) were the most common genotypes. The range of multiple infections varied between two to eight genotypes and the prevalence of multiple HPV infections (12.4%) was higher than single infections (10.4%). For women with single HPV infections, HPV 31 and 66 were equally the most common hrHPV genotypes, followed by HPV 16 and 39. In women with multiple HPV infections, HPV 31 was the most common hrHPV genotype, followed by HPV 51 and 16. For both the single and multiple HPV infections, HPV 6 was the most common lrHPV genotype, followed by HPV 53 and 42.

Conclusion: In conclusion, due to the high prevalence of HPV single and multiple infections, the need for governmentally supported HPV vaccination and through cervical cancer screening should be emphasized to prevent cervical cancer.

Citing Articles

Prevalence of Human Papillomavirus (HPV) Infection and its Association With Pap Smear Findings Among Women Attending a Gynecology Clinic in Khorasan Razavi-Iran.

Etemad S, Asghari Baghalan A, Naeimi B, Mehrzad S, Adib Amin S, Soudyab M J Res Health Sci. 2024; 24(4):e00629.

PMID: 39431654 PMC: 11492526. DOI: 10.34172/jrhs.2024.164.

Distribution of HPV genotypes in Mashhad, Iran: insights from a 2022-2023 study.

Letafati A, Noroozi M, Fallah T, Farahani A, Nasiri M, Pourmoein H Virol J. 2024; 21(1):248.

PMID: 39375749 PMC: 11460210. DOI: 10.1186/s12985-024-02518-4.

Uncommon high distribution of HPV-16, HPV-54, and HPV-56 in female referred to a laboratory in Karaj, Iran: indications of a paradigm shift in HPV genotypes?.

Letafati A, Motlaghzadeh S, Salahi Ardekani O, Memarpour B, Seyedi S, Bahari M Virol J. 2024; 21(1):182.

PMID: 39123176 PMC: 11316285. DOI: 10.1186/s12985-024-02457-0.

Prevalence of HPV Genotypes among Greek Women in Association with Their Potential to Cause Precancerous Lesions.

Kafasi A, Kaparos G, Pitiriga V, Spanakis N, Vlachos N, Thomakos N Microorganisms. 2024; 12(7).

PMID: 39065172 PMC: 11278821. DOI: 10.3390/microorganisms12071404.

References

Herrero R . Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types. J Infect Dis. 2009; 199(7):919-22. DOI: 10.1086/597308. View

Jiang L, Tian X, Peng D, Zhang L, Xie F, Bi C . HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory. PLoS One. 2019; 14(1):e0210311. PMC: 6336302. DOI: 10.1371/journal.pone.0210311. View

Bahramabadi R, Honarvar Z, Iranpour M, Arababadi M, Dehesh T, Dabiri B . Epidemiological Study of Various HPV Strains in Cervical Fluid Samples in South-Eastern Iran, 2018-2020. Arch Iran Med. 2021; 24(9):678-683. DOI: 10.34172/aim.2021.97. View

de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N . Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007; 7(7):453-9. DOI: 10.1016/S1473-3099(07)70158-5. View

Piana A, Sotgiu G, Cocuzza C, Musumeci R, Marras V, Pischedda S . High HPV-51 prevalence in invasive cervical cancers: results of a pre-immunization survey in North Sardinia, Italy. PLoS One. 2013; 8(5):e63395. PMC: 3661560. DOI: 10.1371/journal.pone.0063395. View

Mercado Gutierrez M, Arean Cuns C, Gomez Dorronsoro M, Paniello Alastruey I, Mallor Gimenez F, Lozano Escario M . [Influence of Age in the Prevalence of High-Risk Human Papiloma Virus in Women with Pre-Neoplasic Cervical Lesions in Navarra, Spain]. Rev Esp Salud Publica. 2017; 91. PMC: 11587217. View

Gakidou E, Nordhagen S, Obermeyer Z . Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med. 2008; 5(6):e132. PMC: 2429949. DOI: 10.1371/journal.pmed.0050132. View

Juarez-Gonzalez K, Paredes-Cervantes V, Gordillo-Rodriguez S, Gonzalez-Guzman S, Moncayo-Valencia X, Mendez-Martinez R . High prevalence of human papillomavirus type 66 in low-grade cervical lesions of Mexican women. Arch Virol. 2020; 165(11):2633-2640. DOI: 10.1007/s00705-020-04771-8. View

Baseman J, Koutsky L . The epidemiology of human papillomavirus infections. J Clin Virol. 2005; 32 Suppl 1:S16-24. DOI: 10.1016/j.jcv.2004.12.008. View

10.

Castle P, de Sanjose S, Qiao Y, Belinson J, Lazcano-Ponce E, Kinney W . Introduction of human papillomavirus DNA screening in the world: 15 years of experience. Vaccine. 2012; 30 Suppl 5:F117-22. DOI: 10.1016/j.vaccine.2012.05.071. View

11.

Salavatiha Z, Farahmand M, Shoja Z, Jalilvand S . A meta-analysis of human papillomavirus prevalence and types among Iranian women with normal cervical cytology, premalignant lesions, and cervical cancer. J Med Virol. 2021; 93(8):4647-4658. DOI: 10.1002/jmv.26928. View

12.

Hassani S, Nadji P, Mohseni A, Rahnamaye Farzami M, Mirab Samiee S, Sadr M . Evaluation Frequency of Human Papillomavirus and Its Related Genotypes in Women of the General Population Living in 11 Provinces of Iran. Can J Infect Dis Med Microbiol. 2022; 2022:8668557. PMC: 9072042. DOI: 10.1155/2022/8668557. View

13.

Farahmand Z, Soleimanjahi H, Garshasbi M, Hasanzadeh M, Zafari E . Distribution of the most common types of HPV in Iranian women with and without cervical cancer. Women Health. 2020; 61(1):73-82. DOI: 10.1080/03630242.2020.1822490. View

14.

Kesheh M, Keyvani H . The Prevalence of HPV Genotypes in Iranian Population: An Update. Iran J Pathol. 2019; 14(3):197-205. PMC: 6742734. DOI: 10.30699/ijp.2019.90356.1861. View

15.

Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F . A review of human carcinogens--Part B: biological agents. Lancet Oncol. 2009; 10(4):321-2. DOI: 10.1016/s1470-2045(09)70096-8. View

16.

de Martel C, Plummer M, Vignat J, Franceschi S . Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017; 141(4):664-670. PMC: 5520228. DOI: 10.1002/ijc.30716. View

17.

Hamkar R, Shoja Z, Ghavami N, Heydari N, Farahmand M, Jalilvand S . Type-Specific Human Papillomavirus Prevalence in Iranian Women with Normal Cervical Cytology: The Impact of Current HPV Vaccines. Intervirology. 2018; 60(4):125-130. DOI: 10.1159/000485898. View

18.

Halfon P, Ravet S, Khiri H, Penaranda G, Lefoll C . Incident HPV 51 Infection After Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine Gardasil/Silgard. Clin Med Insights Case Rep. 2011; 3:69-71. PMC: 3046010. DOI: 10.4137/CCRep.S6177. View

19.

Vazifehdoost M, Eskandari F, Sohrabi A . Trends in cocirculation of oncogenic HPV genotypes in single and multiple infections among the unvaccinated community. J Med Virol. 2022; 94(7):3376-3385. PMC: 9314791. DOI: 10.1002/jmv.27706. View

20.

Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S . Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012; 131(10):2349-59. DOI: 10.1002/ijc.27485. View